Almanac 2011: Stable Coronary Artery Disease. The National Society Journals Present Selected Research That Has Driven Recent Advances in Clinical Cardiology

Overview

Journal Mater Sociomed

Date 2013 May 17

PMID 23678298

Authors

Robert A Henderson

Adam D Timmis

Affiliations

Soon will be listed here.

References

Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp C . Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition. Heart. 2009; 96(3):186-9. DOI: 10.1136/hrt.2009.171488. View

Hueb W, Lopes N, Gersh B, Soares P, Ribeiro E, Pereira A . Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2010; 122(10):949-57. DOI: 10.1161/CIRCULATIONAHA.109.911669. View

Ho P, Tsai T, Maddox T, Powers J, Carroll N, Jackevicius C . Delays in filling clopidogrel prescription after hospital discharge and adverse outcomes after drug-eluting stent implantation: implications for transitions of care. Circ Cardiovasc Qual Outcomes. 2010; 3(3):261-6. DOI: 10.1161/CIRCOUTCOMES.109.902031. View

Fox K . COURAGE to change practice? Revascularisation in patients with stable coronary artery disease. Heart. 2009; 95(9):689-92. DOI: 10.1136/hrt.2009.167148. View

Hemingway H, Henriksson M, Chen R, Damant J, Fitzpatrick N, Abrams K . The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model. Health Technol Assess. 2010; 14(9):1-151, iii-iv. DOI: 10.3310/hta14090. View

Buckley B, Murphy A . Do patients with angina alone have a more benign prognosis than patients with a history of acute myocardial infarction, revascularisation or both? Findings from a community cohort study. Heart. 2008; 95(6):461-7. DOI: 10.1136/hrt.2008.146944. View

Boudriot E, Thiele H, Walther T, Liebetrau C, Boeckstegers P, Pohl T . Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol. 2011; 57(5):538-45. DOI: 10.1016/j.jacc.2010.09.038. View

Epstein A, Polsky D, Yang F, Yang L, Groeneveld P . Coronary revascularization trends in the United States, 2001-2008. JAMA. 2011; 305(17):1769-76. PMC: 3164857. DOI: 10.1001/jama.2011.551. View

Mehta S, Frutkin A, Lindsey J, House J, Spertus J, Rao S . Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Interv. 2009; 2(3):222-9. DOI: 10.1161/CIRCINTERVENTIONS.108.846741. View

10.

Gottlieb I, Miller J, Arbab-Zadeh A, Dewey M, Clouse M, Sara L . The absence of coronary calcification does not exclude obstructive coronary artery disease or the need for revascularization in patients referred for conventional coronary angiography. J Am Coll Cardiol. 2010; 55(7):627-34. PMC: 3294287. DOI: 10.1016/j.jacc.2009.07.072. View

11.

James M, Ghali W, Knudtson M, Ravani P, Tonelli M, Faris P . Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography. Circulation. 2011; 123(4):409-16. DOI: 10.1161/CIRCULATIONAHA.110.970160. View

12.

Serruys P, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein A . Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 2009; 5(1):50-6. DOI: 10.4244/eijv5i1a9. View

13.

Hall A, Barth J . Universal definition of myocardial infarction. Heart. 2008; 95(3):247-9. DOI: 10.1136/hrt.2008.147223. View

14.

Harjai K, Shenoy C, Orshaw P, Boura J . Dual antiplatelet therapy for more than 12 months after percutaneous coronary intervention: insights from the Guthrie PCI Registry. Heart. 2009; 95(19):1579-86. DOI: 10.1136/hrt.2009.169896. View

15.

Scheiman J, Devereaux P, Herlitz J, Katelaris P, Lanas A, Veldhuyzen Van Zanten S . Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON). Heart. 2011; 97(10):797-802. PMC: 3088470. DOI: 10.1136/hrt.2010.217547. View

16.

Chan P, Patel M, Klein L, Krone R, Dehmer G, Kennedy K . Appropriateness of percutaneous coronary intervention. JAMA. 2011; 306(1):53-61. PMC: 3293218. DOI: 10.1001/jama.2011.916. View

17.

Blackledge H, Squire I . Improving long-term outcomes following coronary artery bypass graft or percutaneous coronary revascularisation: results from a large, population-based cohort with first intervention 1995-2004. Heart. 2008; 95(4):304-11. DOI: 10.1136/hrt.2007.127928. View

18.

Cohen D, van Hout B, Serruys P, Mohr F, Macaya C, den Heijer P . Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med. 2011; 364(11):1016-26. DOI: 10.1056/NEJMoa1001508. View

19.

Dagenais G, Lu J, Faxon D, Kent K, Lago R, Lezama C . Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease. Circulation. 2011; 123(14):1492-500. DOI: 10.1161/CIRCULATIONAHA.110.978247. View

20.

Sjauw K, Konorza T, Erbel R, Danna P, Viecca M, Minden H . Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. J Am Coll Cardiol. 2010; 54(25):2430-4. DOI: 10.1016/j.jacc.2009.09.018. View